Scientific Advisory Board
The Scientific Advisory Board (SAB), consisting of three independent experts in oncology and immunotherapy, has been established. Major role for the SAB will be to advise in significant scientific issues particularly with regard to decisions regarding changes in direction or conflicts. SAB Members will be invited to attend the annual Meetings of the General Assembly, in order to be updated on the overall progress of the project. At the end of the Meeting they will be requested to provide written considerations, suggestions and criticisms on the project’s advancements. The Scientific Coordinator will share such documents with WP Leaders for discussion and actions to be taken.
HEPAVAC is proud to have the following distinguished Scientists as Members of the SAB:
Prof. Vincenzo Bronte, University of Verona, Verona, Italy;
Prof. Massimo Colombo, Fond. IRCCS Cà Granda Ospedale Maggiore Policlinico & University of Milan, Milan, Italy
Dr. Tim F. Greten, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA